ClinicalTrials.govpublic full text
90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
acute lymphoblastic leukemia, acute myeloid leukemia, myelodysplastic syndrome, secondary acute myeloid leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 917231
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.